• Spin-echo imaging is commonly used for assessment of cardiac and great vessel anatomy. With classic spin-echo imaging, rapidly moving blood appears dark.
• At current fi eld strengths (1.5 and 3.0 tesla), cardiovascular magnetic resonance (CMR) imaging is considered safe for bioprosthetic and mechanical heart valves.
• Older (pre-2000) cardiac pacemakers and implantable defi brillators are an absolute contraindication to higher fi eld (≥0.5 T) CMR. Patients with newer pacemaker systems may be safely scanned using specifi c protocols.
• Cardiovascular magnetic resonance is an important noninvasive technique for evaluating thoracic aortic aneurysms.
• The clinical "gold standard" for the diagnosis of pulmonary embolism is contrast CT angiography (CTA). For patients who are not candidates for CTA due to renal dysfunction or contrast allergic history, pulmonary artery magnetic resonance angiography (MRA) is an excellent noninvasive alternative with high sensitivity and specifi city.
• Cine CMR provides an excellent means for quantitative assessment of left and right ventricular volumes, global ejection fraction, regional systolic function, and biventricular mass.
• Available data suggest dobutamine stress CMR is a sensitive technique for the noninvasive recognition of coronary artery disease (CAD).
• Coronary artery bypass graft patency is well evaluated by spin echo, gradient echo, and gadolinium-diethylenetriamine pentaacetic acid (DTPA)-enhanced threedimensional (3D) enhanced coronary magnetic resonance imaging (MRI).
• Cardiovascular magnetic resonance provides the noninvasive means to assess myocardial viability and fi brosis accurately.
• Cardiovascular magnetic resonance has great value for characterizing paracardiac and extracardiac tumors and their extension into the myocardium, cardiac chambers, or neighboring mediastinal structures.
• Both spin-echo CMR and CT are capable of measuring pericardial thickness accurately.
• Cardiovascular magnetic resonance has great utility for both simple and complex congenital heart disease. Coronary MRI for identifi cation and characterization of anomalous coronary arteries is widely accepted.
More than any other noninvasive imaging technique, the fl exibility of cardiovascular magnetic resonance (CMR) imaging offers the promise to dramatically expand our ability to evaluate patients with known or suspected cardiovascular disease. The combined attributes of superior image quality and fl exibility for assessment of cardiac anatomy, ventricular function, viability, perfusion, valvular function, great vessel anatomy, blood fl ow, and native coronary artery and coronary artery bypass graft integrity give CMR unmatched potential for the comprehensive evaluation of the cardio vascular system. Currently accepted clinical applications of CMR continue to expand rapidly 1 (Table 7 .1). Hardware (gradients and high fi eld systems) advances now allow for sub-second data acquisitions with "real-time" imaging, and software advances and novel contrast agents promise to further exploit CMR's advantages over competing noninvasive imaging methods. The introduction of a comprehensive CMR examination, 2, 3 in which cardiac anatomy, function, viability, perfusion, valvular, and coronary artery assessment is performed during a single 1-hour session, will lead to decreased utilization of other imaging tests (e.g., echo cardiography, radionuclide ventriculography and radionuclide perfusion, diagnostic x-ray coronary angiography), especially for follow-up care/ monitoring. Cardiovascular magnetic resonance training guidelines for both those in fellowship 4, 5 and practitioners who have completed fellowship have now been developed. [5] [6] [7] The relative cost advantage/disadvantage of CMR as compared with these other imaging technologies will need to be defi ned by future cost-effectiveness studies.
Technical Considerations
A review of magnetic resonance (MR) physics is beyond the scope of this chapter, and readers are referred elsewhere. 8, 9 Unlike other imaging techniques, CMR images may depict blood and other tissues as bright, dark, or of an intermediate intensity depending on the specifi c CMR sequence that is employed, the use of exogenous contrast, and whether the tissue of interest (e.g., blood) is rapidly or slowly moving, and whether blood fl ow is laminar or turbulent. The most common CMR approaches are the spin echo ("black blood"), the k-space segmented gradient echo, and the steady-state free precession (SSFP; trueFISP, balanced FFE, FIESTA; "bright blood") sequences.
Spin-echo imaging is commonly used for assessment of cardiac and great vessel anatomy. With classic spin-echo imaging, rapidly moving blood appears dark because a pair (90 and 180 degrees) of sequential radiofrequency (RF) pulses is applied. Rapidly moving blood will move out of the imaging plane during the time interval between these two RF pulses, leading to an absence of signal, or fl ow void (i.e., "black blood"). Stagnant blood, which would be exposed to both RF pulses, will appear relatively bright. Variations may be highlighted when viewing an image containing blood experiencing different phases of the cardiac cycle (e.g., early systole, where there may be rapid fl ow in the ascending aorta with relatively stationary fl ow in the descending thoracic aorta). The fl ow void can be emphasized using thin sections or longer echo times.
With gradient-echo sequences, commonly used for function/cine CMR, a single RF pulse is applied with a much shorter echo time. Little signal is then lost due to washout effects, but stationary tissue (often surrounding blood vessels; e.g., muscle) will be saturated because of repeated RF stimulation. Thus, signal from stationary tissues is suppressed ("dark") due to repeated RF stimulation, while areas of rapid blood fl ow (arterial fl ow) will have continuous infl ow of unsaturated blood with a resultant "bright" signal. Therefore, on gradient-echo images, rapidly moving laminar blood fl ow appears bright, while stagnant blood will appear relatively "dark." In addition, areas of turbulent/chaotic blood fl ow (corresponding to valvular stenoses, aortic insuffi ciency, mitral regurgitation) will appear dark due to local turbulence/phase dispersion. The relative "size" of these signal voids is dependent on the echo time. Steady-state free precession imaging is relatively insensitive to infl ow effects and also depicts blood as bright.
Both gradient-echo and SSFP imaging are commonly used for cine CMR imaging of ventricular and valvular function. For all CMR imaging sequences, specifi c prepulses may highlight or suppress specifi c tissues (e.g., fat saturation prepulse will suppress signal from fat; inversion recovery (180-degree) prepulses will emphasize T1-weighting). Exogenous intravenous contrast [e.g., gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA)] may be used in combination with both spin-echo and gradient-echo approaches and has been particularly valuable for viability assessment of myocardial fi brosis/scar, for assessment of regional myocardial perfusion, and for characterization of tumors/masses. 10 These extracellular CMR contrast agents are minimally nephrotoxic with a highly favorable anaphylaxis profi le. 11,11a Another very useful CMR sequence is phase velocity mapping, in which the velocity of blood perpendicular to the imaging plane is encoded, providing localized fl ow data somewhat analogous to pulsed Doppler echocardiography. This approach is particularly valuable for quantifying regurgitant volumes and fl ows through the great vessels, conduits, and valves.
In contrast to general magnetic resonance applications outside of the heart, the vast majority of CMR applications depend on accurate R wave detection for electrocardiographic (ECG) triggering. In the presence of a rate-controlled irregularly irregular rhythm such as atrial fi brillation, image quality will be acceptable, 12 but high-grade ventricular ectopy or a regularly irregular rhythm (e.g., trigeminy) often leads to signifi cant image degradation. In these situations, real-time CMR is often used, with reduction in spatial and temporal resolution. 13 In limited situations, peripheral pulse (PPU) triggering may be adequate, but we have generally found image quality to be inferior to ECG triggering.
Specifi c Considerations of Cardiovascular Magnetic Resonance in the Cardiac Patient
In addition to general restrictions regarding CMR [ferromagnetic intracranial clips, transcutaneous electrical nerve stimulation (TENS) units, intraauricular implants, shrapnel, etc.], there are also special considerations for CMR (and general magnetic resonance scanning) in the cardiac patient. A comprehensive discussion of CMR safety with regard to implanted devices is beyond the scope of this chapter. Readers are referred to comprehensive sources (www.mrisafety. com).
14 At current fi eld strengths [1.5 and 3.0 tesla (T)], CMR imaging is considered safe for both bioprosthetic and mechanical heart valves.
14 However, a local image artifact (loss of signal/image distortion) will occur in the region immediately surrounding the valve prosthesis ( Fig. 7.1) . Similarly, sternotomy wires, thoracic vascular clips, and ostial coronary artery bypass graft markers are not a contraindication to imaging, but localized artifacts will be present ( Fig. 7. 2), thereby limiting assessment of adjacent structures. The relative size of the image artifact is increased with gradient-echo and SSFP sequences (versus spin-echo sequences). While the composition metal of intracoronary stents will cause a local The area of safety with regard to CMR scanning among patients with cardiac pacemakers and implantable cardiodefi brillators (ICDs) is currently in a state of fl ux. When CMR is the only imaging modality available, uncomplicated CMR has been performed at low fi eld strengths (0.2 T) using specifi c protocols 16 and with proper safeguards in place. Such devices (and the presence of permanent pacemaker leads alone) had been considered an "absolute" contraindication to higher fi eld (≥0.5 T) CMR scanning due to the potential for unpredictable device reprogramming, myocardial stimulation, or heating of the device leads.
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14 Protocols have now been described for safe scanning at 1.5 T for patients with modern (post-2000) pacemaker systems. 17, 18 This area is likely to receive considerable attention and will evolve in the coming years.
Thoracic Aorta and Great Vessels
For many years, CMR had its greatest clinical impact on the assessment of the thoracic aorta in the patient with known or suspected thoracic aortic aneurysm ( Fig. 7 .4) or aortic dissection ( Fig. 7.5 ). Cardiovascular magnetic resonance compares favorably to spiral or multidetector computed tomography (CT) because CMR employ no ionizing radiation or requirement for potentially nephrotoxic iodinated contrast. Comprehensive data regarding the presence of a dissection, entry and exit points, the presence of intraluminal thrombus, involvement of the great vessels, and coexistent aortic insuffi ciency and pericardial effusion are also readily obtained. Transverse, coronal, and sagittal images using ECG gating T1-weighted spin-echo techniques are initially acquired for anatomic imaging. 19, 20 The sine qua non of aortic dissection for spin-echo imaging is the identifi cation of an intimal "fl ap" separating the true and false lumen. Breathhold 3D contrast-enhanced (CE) magnetic resonance angiogram (MRA) is then obtained to defi ne the aortic lumen either with 21 or without 22, 23 ECG gating. Cine SSFP or gradient-echo acquisitions can then be obtained if a dissection fl ap is identifi ed. In addition to the classic fi nding of an intimal fl ap, eccentric aortic wall thickening may also be seen, possibly representing an early dissection or intramural hematoma. 24 In experienced hands, CMR, CT with iodinated contrast, and multiplane transesophageal echocardiography fi ed or suspected on a prior imaging (echocardiography, x-ray angiography) study.
Pulmonary Embolism, Pulmonary Artery, and Pulmonary Vein Assessment
Compared to imaging of the aorta, CMR of the pulmonary artery is more technically demanding of patient cooperation, with breath-holding due to artifacts related to motion as the lungs expand and collapse. Additionally, the pulmonary arteries branch in a complex fashion, with their diameter progressively decreasing at each bifurcation. Finally, susceptibility between the blood-tissue interface and air leads to signal loss at the vessel-lung interface. Although spin-echo approaches can be used to defi ne the anatomy of the pulmonary trunk and the proximal portions of the right and left main pulmonary arteries, 3D CE-MRA is the mainstay of pulmonary artery assessment. 29, 30 This is especially applicable to patients who are suspected of having acute (or chronic) pulmonary thromboembolism. The clinical "gold standard" for the diagnosis of pulmonary embolism is contrast x-ray pulmonary angiography and CT angiography (CTA). The latter has become extremely popular with the widespread availability of multidetector CT scanners in the emergency department. For patients who are not candidates for pulmonary CTA due to renal dysfunction or contrast allergic history, pulmonary artery MRA is an excellent noninvasive alternative with high sensitivity and specifi city. Similar to conventional angiography, pulmonary emboli present as an abrupt discontinuation (signal void) of the arterial lumen ( Fig. 7.7 ). Pulmonary artery dissection is a rare condition that may mimic aortic dissection in symptoms, for which T F FIGURE 7.5. Coronal diastolic frame cine gradient-echo CMR in a patients with an ascending aortic dissection (black arrows). Note the dissection fl ap (black arrows) begins immediately superior to the aortic valve leafl et. Flow is seen in both the true (T) and false (F) lumen. Signal void (white arrow) from local turbulence is seen in the left ventricular cavity immediately below the aortic valve and is due to associated aortic insuffi ciency. (TEE) have similarly high sensitivity, specifi city, and accuracy for identifi cation of thoracic aortic dissection. 19, 20, [25] [26] [27] Cardiovascular magnetic resonance and spiral or multidetector CT have specifi c advantages (as compared with multiplane TEE) for providing information regarding the extent of the dissection into the great vessels and abdominal aorta. Both TEE and CMR also permit determination of aortic valve involvement and aortic insuffi ciency (Fig. 7.5 ), though valve morphology is better defi ned by TEE. Both TEE and CMR can often provide information regarding the involvement of the proximal coronary arteries. Study time and access are important factors in the choice of imaging test. For CMR aortic dissection assessment, a comprehensive assessment can usually be completed within 30 minutes, with close patient monitoring. We generally recommend CMR (or CT) for patients who are hemodynamically stable and for followup studies in younger patients with chronic aneurysms or dissection, refer stable older patients with good renal function to CT, and utilize TEE for those with clinical instability, claustrophobia, or renal dysfunction.
In addition to aortic aneurysm and dissection, CMR is also useful for the assessment of congential aortic lesions such as aortic coarctation (Fig. 7.6 ) and patent ductus arteriosus, as well as more complex abnormalities involving the great vessels (discussed later). Phase velocity methods may be used to quantify velocity gradients 28 as well as fl ow through shunts and to quantify pulmonic-systemic fl ows. From a practical perspective, patients with congenital cardiovascular lesions are often referred for CMR imaging for confi rmation or better defi nition of an abnormality identi-pulmonary artery CE-MRA as well as gradient-echo and spin-echo methods have been shown to be quite accurate. 31 With increasing interest in pulmonary vein ablation as a mainstream therapy for patients with atrial fi brillation, monitoring of patients for asymptomatic pulmonary vein stenosis has become important. Pulmonary vein CE-MRA has been shown to be a very accurate method for monitoring the size of the pulmonary arteries [32] [33] [34] and for identifying stenoses 32, 34, 35 ( Fig. 7.8 ). Preliminary data suggest identifi cation of the ablation site is also possible using delayed enhancement CMR methods. 
Quantitative Assessment of Ventricular Volumes and Mass
Although rarely used for fi rst-line assessment, volumetric cine CMR is becoming increasingly recognized as the clinical gold standard for the quantitative assessment of left and right ventricular volumes, global ejection fraction, regional systolic function, and biventricular mass (Fig. 7.9 ) in patients with known disease. Cardiovascular magnetic resonance is used for validation of ventricular volumes assessed by new technologies such as 3D echocardiography and cardiac CT. [36] [37] [38] Advantages of CMR include the ability to obtain high temporal and spatial resolution tomographic data in true short-and long-axis orientations, the outstanding endocardial border defi nition provided by current SSFP sequences, and the relative ease of data analysis. Semiautomated methods allow for the delineation of the endocardial and epicardial borders with very high accuracy and reproducibility for determination of ventricular volumes, stroke volume, and ejection fraction both in normal and focally deformed ventricles. [39] [40] [41] [42] As compared with M-mode or 2D echocardiography, which is limited to acoustic windows with suboptimal results in many obese and elderly patients, comprehensive, high temporal and spatial resolution true short-axis volumetric data sets are easily acquired in nearly all subjects in less than 8 minutes. Though in theory 3D echocardiography and cardiac CT offer similar volumetric data, the superior spatial (versus 3D echocardiography) and FIGURE 7.9. Enddiastolic (ED) and endsystolic (ES) images from cine short-axis data sets demonstrating the use of endocardial border defi nition and calculation of end-diastolic and end-systolic volumes.
temporal (versus CT) resolutions of CMR make it the strong preference when accurate and reproducible assessments are needed. Volumetric CMR is especially valuable for quantitative information regarding left ventricular volume and mass in patients with asymmetric deformations/hypertrophy, and defi ning cardiomyopathies (such as hypertrophic cardiomyopathy and noncompaction ( Fig. 7.10) , 43 or monitoring ventricular volumes in patients with regurgitant valvular lesions. Left ventricular aneurysms may be recognized as severe wall thinning (less than 4 mm) and diastolic bulging of the left ventricular free wall (Fig. 7.11 ). Left ventricular pseudoaneurysm or false aneurysms may also be readily identifi ed on CMR due to their lack of myocardium in the wall of the aneurysm 44 
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10 μg/kg/min 20 μg/kg/min 40 μg/kg/min of patients. 42, 45, 46 Volumetric CMR methods are also ideal for regional left ventricular assessment with the 17-segment model (six basal, six middle, four apical, with a true apex) 47 that is generally utilized. Left ventricular mural thrombi may be identifi ed on spin-echo images as a density/mass fi lling the left ventricular apex, especially in an area corresponding to a left ventricular aneurysm 44, 48 or as fi lling defects on cine gradient-echo or SSFP imaging. Delayed enhancement (DE) CMR methods may also depict transmural hyperenhancement in the wall of a true aneurysm with the subendocardial area of hypoenhancement corresponding to a chronic left ventricular thrombus 49, 50 ( Fig. 7.11 ). Accurate quantitative evaluation of right ventricular volumes, ejection fraction, and mass is also a relatively unique attribute of CMR. 51 For regional assessment of both right and left ventricular systolic function, myocardial tagging techniques have been shown to be more sensitive for quantitation of local dysfunction, 52, 53 though their clinical role remains to be defi ned.
Detection of Coronary Artery Disease
In addition to ventricular volumes and global/regional systolic function, CMR offers several approaches for detecting and evaluating patients with known or suspected coronary artery disease. These include pharmacologic stress testing with β-agonists (regional dysfunction), vasodilators (perfusion defi cits), viability imaging, and coronary artery imaging.
Due to distortions of the ECG related to the magnetohydrodynamic of pulsatile blood in the aorta, the ECG is uninterpretable for ischemia within the CMR environment. Thus real-time monitoring of wall motion and close patient supervision is imperative. Physiologic stress is possible within the CMR environment, and supine bicycle ergometry units have been developed for such an application, 54 but pharmacologic stress is more commonly used in combination with graded doses of dobutamine (similar protocols to that used for dobutamine stress echocardiography), with cine images typically acquired in the four-and two-chamber orientations along with three short-axis levels (base, middle, apical) at baseline and at each level of dobutamine (Fig. 7.12 ). Data suggest that dobutamine stress CMR is more sensitive for the detection of coronary artery disease (versus dobutamine stress echocardiography). [55] [56] [57] This superiority is directly related to the enhanced ability of CMR to visualize/defi ne all of the myocardial segments. 50 A study that compared dobutamine CMR stress with vasodilator CMR stress found dobutamine wall motion CMR to be superior (Fig. 7.13) . 58 The combination of CMR resting left ventricular ejection fraction and inducible ischemia has prognostic value among patients with known coronary artery disease. 59 Cardiovascular magnetic resonance tagging methods may offer superior sensitivity, 60 but they are less commonly used.
Early applications of CMR myocardial perfusion methods were limited in ventricular coverage, with current methods now acquiring data at three to six short-axis levels during the fi rst passage of Gd-DTPA (0.05 mmol/kg) administered as a tight bolus into the right antecubital fossa. Both visual and quantitative methods (upslope) have been utilized and validated in animal models. [61] [62] [63] Comparison studies with xray angiography and radionuclide imaging are very good. [64] [65] [66] Cardiovascular magnetic resonance protocols of myocardial perfusion may include assessment of perfusion at rest and 
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at peak stress or a single peak-vasodilator assessment with normal resting systolic function used as a surrogate for normal perfusion. Vasodilator perfusion CMR has demonstrated an improvement in myocardial perfusion reserve after a percutaneous coronary intervention 67 and impaired subendocardial perfusion in syndrome X.
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Native Coronary Artery Disease Integrity
Cardiovascular magnetic resonance is used routinely for evaluation of vascular beds throughout the body, but coronary MRI is more technically challenging due to the small caliber, tortuosity, and motion related to both the respiratory and cardiac cycle. As a result, CMR assessment of native coronary artery integrity continues to be a fi eld of rapid evolution with recent competition from coronary CTA methods. The relative strengths of coronary MRI include both the lack of substantial ionizing radiation 69 or the need for potentially nephrotoxic/anaphylactic iodinated contrast, or the need to induce bradycardia with beta-blockade. Another disadvantage of coronary CTA is the diffi culty with lumen integrity assessment among patients with high risk 70 and older patients due to prominent epicardial calcium. 71 Preliminary data suggest that epicardial calcium does not provide the same interference with coronary MRI depiction of the lumen (Fig. 7.14) . 72 Since the initial descriptions of 2D breath-hold coronary MRI, [73] [74] [75] the fi eld has advanced to 3D acquisition methods (double-oblique slab or larger axial stack analogous to coronary CTA) with submillimeter spatial resolution and superior reconstruction capabilities. The spatial resolution of 3D coronary MRI remains inferior to coronary CTA and x-ray coronary angiography, thereby precluding quantitative assessments, although the magnitude of the local signal void does correlate with angiographic stenosis. 75 Data acquisition also remains relatively prolonged at 10 to 20 minutes. Despite this limitation, the feasibility of identifying stenoses in the proximal and midcoronary segments has been demonstrated in several single centers. 76, 77 At present, some approaches (free breathing navigator with real-time motion correction) remain vendor specifi c, making multicenter multivendor trials diffi cult to perform and interpretation of the literature more complicated. We continue to prefer a targeted 3D free-breathing segmented k-space gradient-echo sequence 78, 79 using patient specifi c delay and short acquisition (less than 90 ms/R-R interval) periods. 80 With this approach, high signal intensity (bright blood) represents normal, laminar blood fl ow, with low signal (signal void) at sites of stenosis and focal turbulence (Fig. 7.15 ). Despite superior spatial resolution of multidetector CT, a head-to-head comparison of 3D coronary MRI with 16-slice multidetector (using quantitative x-ray coronary angiography as the gold standard) showed similar diagnostic accuracy, 81 including sensitivity and specifi city of 75% and 77% for coronary MRI and 82% and 79% for coronary CTA, respectively. A multicenter trial of over 100 patients from seven international sites demonstrated high sensitivity but only modest specifi city for identifying focal stenoses, with very high accuracy for discriminating between patients with multivessel disease and no disease. 82 For this reason, we offer coronary MRI as a clinical option for patients presenting with a dilated cardiomyopathy in the absence of a history of acute infarction. Preliminary data from a group of patients with depressed left ventricular systolic function 83 suggest that coronary MRI is superior to DE-CMR for discriminating between these two subsets. Targeted 3D approaches using SSFP methods 84 or a "whole heart" SSFP methodology that supports extensive reconstructions (Fig. 7.16) , 85, 86 somewhat analogous to multidetector computed tomography (MDCT) acquisitions (though inferior in spatial resolution), have been advocated. Comparative data suggest longer vessel segments have been identifi ed, with improved signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) with SSFP whole heart acquisitions, 85, 86 but similar diagnostic results. 84, 86 Preliminary data suggest similar overall results with 3T coronary MRI. 87 It is very likely that coronary MRI methods will get faster and more automated with subsequent application of powerful CT analytic tools to the 3D CMR data sets.
Although not yet routine due to issues of spatial resolution, another advantage of coronary MRI (vs. coronary CTA) is the application of phase velocity fl ow methods to assess coronary artery blood fl ow and fl ow reserve. For patients who ing assessment in these regions. These artifacts, which are commonly located in very close proximity to the coronary arteries or grafts, preclude the assessment of these vessels. As mentioned earlier, both drug eluding stents currently marketed in the United States are FDA approved for CMR scanning immediately after implantation.
Myocardial Viability
Few applications of CMR have been so rapidly embraced by the clinical community as its ability to characterize myocardial fi brosis and thereby derive prognostic data regarding physiologic viability-the likelihood that resting regional left ventricular dysfunction will improve with mechanical revascularization. Extensive correlative CMR and histologic have experienced a myocardial infarction, phase velocity CMR can accurately evaluate the presence of antegrade fl ow in the infarct-related artery. 88 The noninvasive determination of patency infl uences therapy and prognosis in these patients.
Coronary Artery Bypass Graft Patency
In comparison with native vessel coronary MRI, CMR of coronary artery bypass grafts (both saphenous veins and internal mammary arteries) is facilitated by their relatively stationary anterior location, straight and predictable course, and their greater lumen diameter. Adequate fl ow is visualized as a signal void (spin-echo) or as bright signal (gradient-echo, contrast imaging) in the anatomic location corresponding to the expected graft position. Identifi cation of fl ow in at least two contiguous slices, or obtained at different planes perpendicular to the expected bypass graft course suggests patency. If fl ow is suggested at only one level, graft patency is considered "indeterminate," and if there is no evidence of fl ow in any portions of the graft, the graft is considered "occluded." Spin-echo (dark blood), gradient-echo (bright blood), and Gd-DTPA-enhanced 3D coronary MRI have been reported to have higher sensitivity (95-100%) for patency of both saphenous venous and internal mammary grafts. [89] [90] [91] [92] [93] Focal disease can be identifi ed using a 3D coronary MRI sequence 94 ( Fig. 7.17 ). The addition of phase velocity imaging of graft fl ow 95 is also useful for discriminating vein graft patency, especially for jump grafts.
Implanted metallic clips, markers ( Fig. 7.2 ), or intracoronary stents 15, 96 ( Fig. 7. 3) will have a local signal void, preclud- studies in animal models have demonstrated that extracellular Gd-DTPA will localize/concentrate to areas corresponding to scar/fi brosis on histology and can be recognized using delayed enhancement CMR imaging. 97, 98 Using an inversion recovery sequence with imaging 10 to 20 minutes following injection of 0.1 to 0.2 mmol/kg of Gd-DTPA, areas of hyperenhancement correspond to scar/fi brosis (Fig. 7.11 ) with highly reproducible results. 99 Delayed-enhancement CMR studies have demonstrated that the lack of hyperenhancement is a very strong predictor of functional viability (Fig. 7.13) , while the presence of more than 50% transmural hyperenhancement is a powerful predictor for the lack of functional recovery. [100] [101] [102] An intermediate fi nding (1% to 49% transmurality) is less useful. For this group, regional systolic response to low-dose dobutamine appears superior 58 ( Fig. 7.13 ). Delayed-enhancement CMR also compares favorably with electromechanical mapping 103 and clinical positron emission tomography. 104 The DE-CMR method appears to be particularly superior to wall thinning for the discrimination of viable myocardium. Anecdotal reports 105 and preliminary data from a multicenter series 106 reported that 20% of subjects with thinned, akinetic segments have lack of hyperenhancement of those segments. Following mechanical revascularization, these segments demonstrate markedly improved systolic thickening in addition to local hypertrophy/normalization of diastolic wall thickness. Delayed-enhancement CMR also appears to be superior to global left ventricular ejection fraction for identifi cation of patients with underlying substrate for sustained ventricular tachycardia.
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Nonischemic Cardiomyopathies
Initial studies suggested that hyperenhancement may be specifi c for coronary artery disease. 108 Subsequent studies have shown that hyperenhancement may occur in a variety of nonischemic myopathic conditions including hypertrophic cardiomyopathy [109] [110] [111] (Fig. 7.18 ), Fabry's disease, 112 sarcoidosis, 113 myocarditis, 114, 115 and Churg-Strauss syndrome. 116 A diffuse pattern of hyperenhancement is seen in amyloid cardiomyopathy. 117 Though not totally specifi c for myocardial infarction, a subendocardial hyperenhancement corresponding to a coronary artery distribution is far more common among patients with ischemic cardiomyopathy, while patients with nonischemic myopathies more often demonstrate a hyperenhancement pattern of the midventricular or epicardial layers that also do not correspond to a coronary distribution. 110, 112, [114] [115] [116] Two studies 83, 118 have suggested that the pattern may be used to characterize the cause of a dilated cardiomyopathy, although 25% of patients with a "coronary disease" hyperenhancement pattern had a nonischemic myopathy. Thus, coronary MRI may be superior. 83 Among patients with a dilated cardiomyopathy given carvedilol, the absence of hyperenhancement predicts a regional improvement in systolic function, global improvement in left ventricular ejection fraction, and decrease in left ventricular cavity size. 119 The ability of CMR to acquire images of the entire heart in true tomographic planes makes it ideal for the evaluation of patients with hypertrophic cardiomyopathies, especially important for evaluation of patients with focal/asymmetric hypertrophy ( Fig. 7.18 ). Both DE-CMR 109-111 and investigative CMR "tagging" methods may assist in the assessment of these patients, 120 though the latter remains to be more fully elucidated. Serial CMR examinations may be useful to monitor ventricular remodeling and infarction size following alcohol ablation. 121 In addition to biventricular volumetric and mass data, CMR may confi rm excess iron deposition 122 as the cause of depressed systolic function in a patient with suspected hemochromatosis. Assessment of septal T2* has been shown to refl ect myocardial iron stores, with T2* of less than 20 ms indicating iron overload. be used to identify transmural or focal fatty infi ltration in the right ventricular free wall as well as focal wall thinning (Fig. 7.19) . 124, 125 Delayed-enhancement CMR with right ventricular free wall hyperenhancement has also been described, 126 with the clinical history best able to discriminate hyperenhancement due to right ventricular infarction from that of a primary cardiomyopathy.
Valvular Heart Disease
The clinical adoption of CMR in the care of patients with valvular heart disease is expanding. Once almost solely the province of 2D and Doppler echocardiography, the unique quantitative nature of CMR with regard to ventricular volumes and function, as well as the ease in calculation of regurgitant volumes, has brought CMR to the clinical arena for the care of this large group of patients. Valve morphology (e.g., bicuspid valve) is easily recognized by CMR with acquisition of a cine SSFP data set through the plane of the aortic valve. For now, leafl et thickening, calcifi cation, vegetations, abscess, and minor degrees of mitral valve prolapse largely remain the province of echocardiography, though obvious prolapse and partial leafl et fl ail are readily identifi ed on cine CMR imaging.
For the assessment of aortic valve stenosis, two CMR approaches are utilized: a morphologic/2D assessment with planimetry of the maximum systolic aortic valve area 127 on orthogonal cine SSFP sequences, and a continuity equation "equivalent."
128 Diffi culties with the anatomic (2D measures) include orientation of the slice among patients with markedly deformed valves, while diffi culties with the continuity equation approach include orientation of the imaging plane perpendicular to the maximal velocity jet and dephasing/ artifacts due to turbulence in patients with severe aortic stenosis. Analogous approaches are used for assessing mitral stenosis, including 2D planimetry of the mitral valve area as defi ned by a cine acquisition oriented orthogonal to the valve plane 129 and with the use of phase velocity mapping at the level of the mitral leafl et tips, 130 thereby applying a pressurehalf-time equivalent measurement. Diffi culties with the former again include proper orientation orthogonal to fl ow, while limitations of the latter include the relatively poor temporal (vs. Doppler echocardiography) resolution and diastolic artifacts among the many patients with coexistent mitral stenosis and atrial fi brillation.
The use of CMR for the quantitative assessment of valvular regurgitation is much more direct and highly quantitative. Qualitative assessment of mitral and aortic regurgitation had initially been by qualitative estimate of the fl ow disturbance (signal void) in the receiving chamber in a manner somewhat analogous to color Doppler. These early studies showed a good correlation with Doppler echocardiography. 131 However, the subsequent introduction of strong gradients and shorter echo times led to attenuation and near elimination of the dephasing artifact. 132 This is particularly true of the newer SSFP acquisitions, which have become "standard" at most CMR centers, with the nearly complete elimination of regurgitant jets. Fortunately, CMR offers a more quantitative approach. Using phase velocity mapping, fl ow is measured across the aortic valve (from a practical perspective, this is often obtained in the axial plane at the level of the bifurcation of the pulmonary artery). Such an assessment includes a direct quantitative assessment of aortic regurgitation (Fig. 7.20) . For mitral regurgitation, we generally quantify the mitral regurgitant volume as the difference between the left ventricular stroke volume (derived from the contiguous short axis left ventricular stack) and the forward fl ow out of the aorta. Another option is to directly measure mitral regurgitation volume using phase velocity mapping at the level of the mitral annulus. We have found the latter approach to be technically more challenging due to the base to apex motion of the annulus during systole and eccentric, highvelocity mitral regurgitation jets, which sometimes lead to errors, analogous to some of the limitations of quantitative Doppler echocardiography.
Beyond simple calculation of regurgitant volume, CMR provides for the ready determination of regurgitant fraction (regurgitant volume/stroke volume), regurgitant volume index (regurgitant volume/end-diastolic volume), and effec- tive forward ejection fraction (net forward stroke volume/ end-diastolic volume). These same measures can be equally well applied for pulmonic and tricuspid regurgitation. Another advantage of CMR versus echocardiography and invasive measures is the ability to easily quantify the regurgitant volumes attributable to each valve in the presence of serial regurgitant lesions (e.g., mitral regurgitation and aortic regurgitation).
Cardiac Tumors and Masses
Although the high spatial resolution of CMR allows for depiction of intracavitary tumors/masses (e.g., myxoma), these intracavitary "masses" are generally well appreciated and characterized using conventional echocardiography (transthoracic or transesophageal). However, the sensitivity and accuracy of transthoracic echocardiography for mural left ventricular thrombi has recently been called into question by an operative series that suggested far superior accuracy of DE-CMR (Fig. 7.11) . 49, 50 Cardiovascular magnetic resonance also has great value for characterizing paracardiac and extracardiac tumors 133 and their extension into the myocardium, cardiac chambers, or neighboring mediastinal structures (e.g., vena cavae, pulmonary veins). The ability of 3D CMR data sets to be reconstructed in any orientation helps to guide the surgical approach in such situations.
Though rarely diffi cult to diagnose from echocardiographic images, benign lipomatous hypertrophy of the interatrial septum as visualized on transthoracic echocardiography (TTE) or TEE may sometimes lead to the misdiagnosis of an atrial septal "tumor." The characteristic, very intense signal from fatty tissue 134 with suppression using a fat saturation prepulse readily allows for the CMR diagnosis of this benign disorder.
Pericardium
The normal pericardium extends around the heart as a thin black line between visceral and parietal pericardial fat on spin-echo CMR imaging. Normal pericardial thickness is 3 mm or less. 135 Among patients presenting with constrictive cardiomyopathy, often following recurrent pericarditis or mediastinal radiation, the pericardium is thickened (Fig.  7.21 ), a fi nding that is readily appreciated by ECG-triggered spin-echo CMR. Gradient-echo methods are slightly less reliable for pericardial thickness. 136 Computed tomography is also valuable in this situation, and is better suited for the specifi c assessment of pericardial calcifi cations (see Chapter 67) . It should be remembered, however, that while CMR (and CT) will accurately quantify focal pericardial thickening, the presence of thickened pericardium alone is not diagnostic of constrictive physiology, and constriction may be present in the absence of pericardial thickening. 137 Cardiovascular magnetic resonance tagging methods demonstrate adherence of the pericardium to underlying epimyocardium. 138 Among patients with constriction, CMR also frequently demonstrates thickened pericardium in concert with an enlarged inferior vena cava alone, right atrial and right ventricular enlargement, 136 and abnormal septal motion (with real-time CMR). Though echocardiography is generally adequate for circumferential effusions, CMR depicts transudative effusions as areas of high intensity and may be particularly helpful in the delineation of loculated effusions, especially in patients with suboptimal echocardiographic windows. Delineation of hemorrhagic and transudative effusions is another attribute of CMR.
Congenital Heart Disease
An extensive review of CMR applications for congenital heart disease is beyond the scope of this chapter. As previously mentioned, CMR has great utility for both simple and complex congenital heart disease. While hemodynamically signifi cant atrial septal defects and ventricular septal defects are usually identifi able by TTE or TEE, phase-velocity CMR is highly accurate and valuable for quantifying the pulmonary/systemic fl ow ratio in patients with known defects 139 and characterizing congenital heart disease outside of the cardiac chambers. These defects include aortic coarctation ( Fig. 7.6 ), anomalous pulmonary venous drainage (Table 7 .1; Fig. 7 .22), and complex congenital heart disease in patients who have undergone corrective or palliative surgery. For these patients, CMR defi nes structural components and their relationships, including serial evaluation and planning of subsequent surgical interventions. Coronary MRI for identifi cation and characterization of anomalous coronary arteries is widely accepted as a clinical tool. This condition is found in less than 2% of the population and is generally benign. However, there is an increased risk of sudden death and myocardial infarction when the anomalous vessel courses between the aorta and pulmonary artery (Fig. 7.23 ). Even among patients with anomalous coronary arteries identifi ed by invasive x-ray angiography, the anatomic course of the vessel may be misinterpreted owing to the projection method or operator inexperience, especially with the declining routine use of right heart catheterization, making coronary MRI a preferred approach. Several studies have now reported on the value of MR in this condition, [140] [141] [142] [143] including the fi nding of initial misinterpretation by conventional x-ray angiography. 141, 143 Though coronary MRI data for anomalous disease are quite extensive, in the absence of a strong suspicion, data are not suffi cient to support routine coronary CMR screening among young adults who present with chest pain. Coronary CTA likely has similar effi cacy, though it has been less well studied and would expose young adults to potentially harmful ionizing radiation.
Summary
Over the past decade, there has been tremendous clinical growth in CMR. The recent introduction of high fi eld (e.g., 3 T) CMR systems 144 and application of parallel imaging methods 145 in CMR has the potential to dramatically decrease the time needed for CMR study completion. Moreover, investigations in the use of CMR for detection of subclinical disease are ongoing 146 and expected to further expand the role of CMR in clinical care. Finally, the enhancement of realtime CMR has facilitated the exciting birth of interventional CMR methods, including placement of percutaneous valves and atrial septal defect closure devices as well as guidance for electrophysiologic procedures. Intervention CMR is expected to have its greatest initial impact in the pediatric population, 147 for which radiation exposure is of greatest concern. 
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